These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19122386)

  • 1. HSV-1 infection through inhibitory receptor, PILRalpha.
    Satoh T; Arase H
    Uirusu; 2008 Jun; 58(1):27-36. PubMed ID: 19122386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B.
    Satoh T; Arii J; Suenaga T; Wang J; Kogure A; Uehori J; Arase N; Shiratori I; Tanaka S; Kawaguchi Y; Spear PG; Lanier LL; Arase H
    Cell; 2008 Mar; 132(6):935-44. PubMed ID: 18358807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesis.
    Arii J; Wang J; Morimoto T; Suenaga T; Akashi H; Arase H; Kawaguchi Y
    J Virol; 2010 Oct; 84(20):10773-83. PubMed ID: 20686018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects on cell fusion activity of mutations in herpes simplex virus 1 glycoprotein B (gB) dependent on whether a gD receptor or a gB receptor is overexpressed.
    Fan Q; Lin E; Satoh T; Arase H; Spear PG
    J Virol; 2009 Aug; 83(15):7384-90. PubMed ID: 19457990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino terminus of herpes simplex virus 1 glycoprotein K is required for virion entry via the paired immunoglobulin-like type-2 receptor alpha.
    Chowdhury S; Chouljenko VN; Naderi M; Kousoulas KG
    J Virol; 2013 Mar; 87(6):3305-13. PubMed ID: 23302878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry.
    Fan Q; Amen M; Harden M; Severini A; Griffiths A; Longnecker R
    J Virol; 2012 Apr; 86(8):4468-76. PubMed ID: 22345445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of herpes simplex virus glycoprotein B (gB) to paired immunoglobulin-like type 2 receptor alpha depends on specific sialylated O-linked glycans on gB.
    Wang J; Fan Q; Satoh T; Arii J; Lanier LL; Spear PG; Kawaguchi Y; Arase H
    J Virol; 2009 Dec; 83(24):13042-5. PubMed ID: 19812165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoring Herpesvirus Entry Mediator (HVEM) Immune Function in HVEM
    Tormanen K; Wang S; Jaggi U; Ghiasi H
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32522859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ig-like v-type domain of paired Ig-like type 2 receptor alpha is critical for herpes simplex virus type 1-mediated membrane fusion.
    Fan Q; Longnecker R
    J Virol; 2010 Sep; 84(17):8664-72. PubMed ID: 20573830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping sites of herpes simplex virus type 1 glycoprotein D that permit insertions and impact gD and gB receptors usage.
    Fan Q; Kopp S; Connolly SA; Muller WJ; Longnecker R
    Sci Rep; 2017 Mar; 7():43712. PubMed ID: 28255168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.
    Krummenacher C; Baribaud F; Ponce de Leon M; Baribaud I; Whitbeck JC; Xu R; Cohen GH; Eisenberg RJ
    Virology; 2004 May; 322(2):286-99. PubMed ID: 15110526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha.
    Arii J; Uema M; Morimoto T; Sagara H; Akashi H; Ono E; Arase H; Kawaguchi Y
    J Virol; 2009 May; 83(9):4520-7. PubMed ID: 19244335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α.
    Chowdhury S; Naderi M; Chouljenko VN; Walker JD; Kousoulas KG
    Virol J; 2012 Jun; 9():112. PubMed ID: 22695228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection.
    Maeda N; Furukawa A; Kakita K; Anada M; Hashimoto S; Matsunaga S; Kuroki K; Ose T; Kato A; Arii J; Kawaguchi Y; Arase H; Maenaka K
    Biol Pharm Bull; 2016; 39(11):1897-1902. PubMed ID: 27803463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between herpesvirus entry mediator and HSV-2 glycoproteins mediates HIV-1 entry of HSV-2-infected epithelial cells.
    Hu K; He S; Xiao J; Li M; Luo S; Zhang M; Hu Q
    J Gen Virol; 2017 Sep; 98(9):2351-2361. PubMed ID: 28809154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.
    Stiles KM; Whitbeck JC; Lou H; Cohen GH; Eisenberg RJ; Krummenacher C
    J Virol; 2010 Nov; 84(22):11646-60. PubMed ID: 20826693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry.
    Whitbeck JC; Peng C; Lou H; Xu R; Willis SH; Ponce de Leon M; Peng T; Nicola AV; Montgomery RI; Warner MS; Soulika AM; Spruce LA; Moore WT; Lambris JD; Spear PG; Cohen GH; Eisenberg RJ
    J Virol; 1997 Aug; 71(8):6083-93. PubMed ID: 9223502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
    Patrusheva I; Perelygina L; Torshin I; LeCher J; Hilliard J
    J Virol; 2016 Oct; 90(20):9420-32. PubMed ID: 27512063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of cellular HSV-1 receptor expression in human brain.
    Lathe R; Haas JG
    J Neurovirol; 2017 Jun; 23(3):376-384. PubMed ID: 27981441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.